ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

Rauscher Responds To Criticism

March 21, 1975